PROMETHEUS BIOSCIENCES, INC. Deferred Revenue (Non-Current)
PROMETHEUS BIOSCIENCES, INC. had Deferred Revenue (Non-Current) of $15.48 million as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2023-05-09
- 2023-03-31: Deferred Revenue, Noncurrent $15.48M.
- 2022-12-31: Deferred Revenue, Noncurrent $15.67M.
- 2022-09-30: Deferred Revenue, Noncurrent $15.64M.
- 2022-06-30: Deferred Revenue, Noncurrent $15.73M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2023-03-31 | $15.48M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $15.67M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $15.64M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $15.73M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $15.80M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $16.20M 10-K · filed 2023-02-28 |
| 2021-09-30 | $11.74M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $13.04M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.65M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $4.60M 10-K · filed 2022-03-09 |